Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 19, 2016 at 12:25 PM EDT

Sarepta Scores Big on Highly Contested FDA Approval

Sarepta Therapeutics cleared another hurdle related to its Duchenne muscular dystrophy treatment, and the stock practically doubled on Monday.

Chris Lange | Sep 19, 2016 at 10:20 AM EDT

Community Health May Be Planning Sale

Shares of Community Health Systems retreated on Monday, after making a sizable gain in Friday’s session on news that the…

Lee Jackson | Sep 19, 2016 at 8:25 AM EDT

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

Chris Lange | Sep 16, 2016 at 10:35 AM EDT

Is This the Ultimate Implosion of Novavax?

Novavax was pummeled by shareholders on Friday after the company reported top-line results from its RSV F Vaccine trials.

Chris Lange | Sep 16, 2016 at 7:20 AM EDT

Has AcelRx Pharmaceuticals Hit a Home Run?

Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an…

Chris Lange | Sep 15, 2016 at 12:35 PM EDT

Caladrius Bio Jumps on Private Placement Deal

Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.

Chris Lange | Sep 15, 2016 at 8:40 AM EDT

Why Aeri Pharma Won So Big on a Single Trial

Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in…

Chris Lange | Sep 14, 2016 at 4:37 PM EDT

Why This FDA Departure Is Huge for Sarepta

Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne…

Jon C. Ogg | Sep 14, 2016 at 3:02 PM EDT

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars

It is not that often that you see biotech or biohealth stocks moving north of 50% in one trading session.…

Chris Lange | Sep 14, 2016 at 10:35 AM EDT

Agios Files for Secondary Offering

Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.

Chris Lange | Sep 14, 2016 at 10:25 AM EDT

Vitae Shares Jump Over 150% on Allergan Acquisition

The goal of Allergan’s bid for Vitae Pharmaceuticals is to bolster its dermatology product pipeline, and Vitae shareholders appear happy…

Chris Lange | Sep 14, 2016 at 8:20 AM EDT

Key FDA Decisions and Trial Results Coming in the Next 2 Months

24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

1 … 194 195 196 197 198 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Sarepta Scores Big on Highly Contested FDA Approval

Community Health May Be Planning Sale

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Is This the Ultimate Implosion of Novavax?

Has AcelRx Pharmaceuticals Hit a Home Run?

Caladrius Bio Jumps on Private Placement Deal

Why Aeri Pharma Won So Big on a Single Trial

Why This FDA Departure Is Huge for Sarepta

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars

Agios Files for Secondary Offering

Vitae Shares Jump Over 150% on Allergan Acquisition

Key FDA Decisions and Trial Results Coming in the Next 2 Months

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Short Sellers Run for Cover From Major Biotechs

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Health and Healthcare Articles

All Health and Healthcare Articles

Sarepta Scores Big on Highly Contested FDA Approval

Community Health May Be Planning Sale

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Is This the Ultimate Implosion of Novavax?

Has AcelRx Pharmaceuticals Hit a Home Run?

Caladrius Bio Jumps on Private Placement Deal

Why Aeri Pharma Won So Big on a Single Trial

Why This FDA Departure Is Huge for Sarepta

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars

Agios Files for Secondary Offering

Vitae Shares Jump Over 150% on Allergan Acquisition

Key FDA Decisions and Trial Results Coming in the Next 2 Months

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Short Sellers Run for Cover From Major Biotechs

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check